BrainCool has successfully transitioned to fully automated injection molding for half of its disposable products. The change has reduced manufacturing costs for consumables by 33 percent compared to the first quarter of 2024. The company is targeting a total cost reduction of 45 percent by 2026. The efficiency gains have been made possible through increased automation and technical process improvements, including the integration of injection molding and gluing robots into production.
|
Published October 15, 2025
BrainCool reduces manufacturing costs by 33 percent
Text:
News Desk [email protected]
Notes
Lundbeck enters the fight for Avadel
Klaria's partner CNX starts production of migraine film
Sofinnova Partners raises EUR 650 million in new fund
Merck acquires Cidara for approximately USD 9,2 billion
Coegin Pharma launches first Follicopeptide product
Ascelia Pharma receives FDA acceptance for Orviglance application
Diamyd Medical passes safety review ahead of Phase III readout
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account